BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3200378)

  • 1. Treatment of extraneural metastatic medulloblastoma with a combination of cyclophosphamide, adriamycin, and vincristine.
    Chamberlain MC; Silver P; Edwards MS; Levin VA
    Neurosurgery; 1988 Oct; 23(4):476-9. PubMed ID: 3200378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraneural metastases from medulloblastoma: long-term survival after sequentially scheduled chemotherapy and radiotherapy.
    Mahoney DH; Steuber CP; Sandbach JF; Fernbach DJ
    Med Pediatr Oncol; 1986; 14(6):329-31. PubMed ID: 3784985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.
    Friedman HS; Mahaley MS; Schold SC; Vick NA; Falletta JM; Bullard DE; D'Souza BJ; Khandekar JD; Lew S; Oakes WJ
    Neurosurgery; 1986 Mar; 18(3):335-40. PubMed ID: 3703192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
    Leo E; Schlegel PG; Lindemann A
    J Neurooncol; 1997 Apr; 32(2):149-54. PubMed ID: 9120544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
    Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
    Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraneural metastatic medulloblastoma in an adult.
    Wendland MM; Shrieve DC; Watson GA; Chin SS; Blumenthal DT
    J Neurooncol; 2006 Jun; 78(2):191-6. PubMed ID: 16598430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
    Clement J; Varlotto J; Rybka W; Frauenhoffer E; Drabick JJ
    J Clin Oncol; 2013 Jul; 31(19):e316-9. PubMed ID: 23715566
    [No Abstract]   [Full Text] [Related]  

  • 8. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS; Chamberlain MC; Glantz MJ; Wang S
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of small cell lung cancer with cyclophosphamide, adriamycin and vincristine (CAV) combination therapy: experience at University Hospital, Kuala Lumpur, Malaysia.
    Lee SM
    Singapore Med J; 1990 Aug; 31(4):317-20. PubMed ID: 2175049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraneural Metastases From Desmoplastic Medulloblastoma Masquerading as Lymphoma.
    Mahajan A; Paul P; Sridhar E; Rangarajan V; Gupta T; Chinnaswamy G; Moiyadi A; Jalali R
    Clin Nucl Med; 2017 May; 42(5):354-357. PubMed ID: 28263211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review.
    Kushner BH; Meyers PA
    J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation.
    Lundberg JH; Weissman DE; Beatty PA; Ash RC
    J Neurooncol; 1992 Jun; 13(2):151-5. PubMed ID: 1432032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraneural metastases from cerebellar medulloblastoma.
    Lowery GS; Kimball JC; Patterson RB; Raben M
    Am J Pediatr Hematol Oncol; 1982; 4(3):259-62. PubMed ID: 7149167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
    Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G
    J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
    Al-Hader AA; Jain A; Al-Nasrallah N; Einhorn LH
    Am J Clin Oncol; 2015 Aug; 38(4):364-6. PubMed ID: 23799289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, adriamycin and cisplatin (CAP) versus cyclophosphamide, adriamycin and vincristin (CAV) in the treatment of advanced ovarian cancer: a randomized study.
    Krommer CF; Szalai JP
    Ann Oncol; 1992 Jan; 3(1):37-9. PubMed ID: 1606067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of molecularly profiled extraneural medulloblastoma metastases in a child.
    Mobark NA; Al-Harbi M; Mosleh O; Santagata S; Snuderl M; Abedalthagafi M
    BMC Med Genet; 2018 Jan; 19(1):10. PubMed ID: 29343221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.